Your browser doesn't support javascript.
loading
Impact of a drug allergy education course for non-specialists: Findings from ADAPT-A randomized crossover trial.
Lucas, Michaela; Mak, Hugo W F; Lee, Jasmine T Y; Kulkarni, Rishabh; Chan, Sophia S C; Li, Philip H.
Afiliação
  • Lucas M; Immunology Department, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
  • Mak HWF; Medical School, University of Western Australia, Perth, Western Australia, Australia.
  • Lee JTY; Immunology Department, Perth Children's Hospital, Perth, Western Australia, Australia.
  • Kulkarni R; Immunology Department, PathWest Laboratory Medicine, Perth, Western Australia, Australia.
  • Chan SSC; Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong.
  • Li PH; Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong.
Allergy ; 2024 Aug 07.
Article em En | MEDLINE | ID: mdl-39109415
ABSTRACT

BACKGROUND:

The consequences of drug allergy remain a global health concern. Drug allergy is often a neglected topic and many non-specialists lack sufficient knowledge or confidence in evaluating or managing this common condition. Evidence-based interventions to better equip non-specialists to tackle drug allergy are needed. The aim of the study is to evaluate the effectiveness of an intensive educational course on drug allergy knowledge and practice of non-specialists.

METHODS:

A randomized crossover trial (NCT06399601) was conducted among practicing physicians and nurses participating in an intensive drug allergy course-Advances in Drug Allergy & Penicillin Testing (ADAPT). Participants' baseline knowledge and self-reported practices were assessed with standardized questionnaires (scored from 0 to 100, with "satisfactory" defined as ≥60/100). Participants were randomized into two cohorts and attended ADAPT at different time points. Serial responses before and after the course were compared within and between cohorts.

RESULTS:

Seventy participants (25 physicians, 45 nurses) randomized into two groups completed the course. Baseline drug allergy knowledge (58.0 ± 19.9) and self-reported practice (36.9 ± 24.3) were unsatisfactory among non-specialists, with significantly lower scores from nurses than physicians in both domains (knowledge 49.0 ± 17.4 vs. 74.0 ± 12.7; practice 32.1 ± 21.3 vs. 53.3 ± 23.1; all p < 0.001). Following completion of ADAPT, participants demonstrated significant improvements in knowledge (58.0 ± 19.9 vs. 77.7 ± 15.9, p < 0.001) and self-reported practice (36.9 ± 24.3 vs. 71.0 ± 20.2, p < 0.001). All participants (100%) and 99% of participants agreed that the course improved their clinical knowledge and practice, respectively.

CONCLUSIONS:

ADAPT, an intensive drug allergy educational course was effective in improving drug allergy knowledge and practice for non-specialists. Further longitudinal studies are required to evaluate long-term impact.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Allergy Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Allergy Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália